as class 2B, possible human carcinogens (IARC, 1993a; 1993b) . AFM1 level in milk and in milk products is regulated in several countries; the European Union (EU) limit of 0.05 µg/kg being one of the lowest in the world (EC, 2003a) . In contrast, no regulation for OTA in milk exists, even though it has been suggested that OTA level in cow's milk may exceed the tolerable daily intake (TDI) of 5 ng/kg b.w. per day for small children in some areas in
Norway (Skaug, 1999) .
The Scientific Committee for Food (SCF) reviewed the toxicology on OTA and concluded in its opinion on OTA in food on the 17 th September 1998 (SCF, 1998 that there is an increasing concern about potential genotoxicity of OTA and its mechanism of action as a carcinogen. Therefore the Committee considered it would be prudent to reduce exposure to Aflatoxins are predominantly produced in hot climates. In temperate countries, the strict control of imported feeds has limited the cases of milk contamination above the maximum tolerable limits. However, the presence of aflatoxins was recently reported in feeds (EC, 2003b; EFSA, 2004) . The emergence of aflatoxins in the European continent is concurrent with the increase in the annual average temperature registered in the past decade (Anderson et al., 2004) .
Investigations on milk AFM1 contamination are regularly conducted in European countries (EFSA, 2004) , but there is little information on the milk contamination by other mycotoxins. In particular, there is scarce information on the presence of OTA in cow's milk (Skaug, 1999; Breitholtz-Emanuelsson et al., 1993; Valenta and Goll, 1996) , and no data are available in Italy concerning infant milk-based formula contamination by this mycotoxin.
Consumption of cow's milk has not previously been considered as possible source of OTA intake, because of the microflora in the rumen hydrolyses OTA to the less toxic metabolite ochratoxin α (Hult et al., 1976; Sreemannarayana et al., 1988) . However, OTA has been found in bovine milk, in low concentrations, indicating that small amounts may escape rumen metabolism and are absorbed (Skaug, 1999; Breitholtz-Emanuelsson et al., 1993) . The OTA concentration in cow's milk is expected to be very low, but even low concentrations might markedly increase OTA daily intake by consumers of large quantities of milk such as children, and contribute to significant portion of the total dietary intake (Skaug, 1999).
After birth, infant formulas constitute an important or often sole source of food for newborns and infants during the first months of life. Thus, these formulas have a special role in the infant diet because they should serve as substitutes for human milk. It is desirable that infant formulas should be proportionally similar or inferior in AFM1 and OTA levels to those found by human milk. In general, AFM1 and OTA concentrations in breast milk show marked variability depending on mother's life style and dietary habits. OTA was detected in milk from healthy mothers in Germany, Norway, Sweden, Hungary, Italy, Australia and Sierra
Leone (Scott, 2005) . Previous data from Italy had indicated a high prevalence of OTA in human milk samples with concentrations ranging between 1700-6600 ng/L and 100-12000 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w  O  n  l  y   5 ng/L, respectively (Micco et al., 1991; 1995) . A second study has been carried out in Italy (Turconi et al., 2004) . OTA was detected in 198 samples (85.7%) at an average value of 6.01 ng/L. More recently, data from milk samples collected from 82 Italian women indicated that 74% of human milk samples contained OTA in the range < 5 ng/L-405 ng/L (Galvano et al., 2008) . In the same study AFM1 was detected in four (5%) of milk samples (ranging from < 7 ng/L to 140 ng/L) (Galvano et al., 2008) . Relatively little work on the topic of mycotoxins in infant food has been reported in the literature (Galvano et al., 1998; 2001; Lombaert et al., 2003; Tam et al., 2006; Beretta et al., 2002) . Most data have only been part of larger surveys of cereal foods (Lombaert et al., 2003; Tam et al., 2006; Beretta et al., 2002) .
For these reasons, the aim of the following work was to determine AFM1 and OTA levels in the leading brands of infant formulas marketed in Italy, and then, to assess their repercussion in the provisional tolerable weekly intake of OTA and of AFM1. formulas were classified as pre-term formula (n = 11; 1 powder and 10 liquid) and starter formula for infants from the first day to 6 months of age (n = 26, 16 powder and 10 liquid). Table 1 and 2 report their main characteristics. Mycotoxins are highly toxic substances, precautions must be observed when handling these substances, safety instructions for working with mycotoxins are given in Valenta (1998). All mycotoxins waste and contaminated laboratory materials were kept for 24 h in sodium hypochlorite solution (household bleach) for decontamination. Spiked samples. Samples spiked before extraction were used to check the performance of the extraction and clean-up procedure and to obtain validation parameters. Spiking solutions of mycotoxins were prepared daily by dilution with HPLC mobile phases. For samples of liquid adding appropriate volume of the spiking solution of mycotoxins to the milk suspension (described above) and then processed as for liquid milk.
Standard preparation

OTA (from
High-performance liquid chromatography
The chromatographic system consisted of Jasco880 pump and Jasco821 fluorescence detector (Jasco, Tokyo, Japan). JascoBorwin software was used for data processing. The excitation wavelength (λex) and emission wavelength (λem) were set at 380 and 420 nm for OTA and at 365 and 435 nm for AFM1, respectively. The reversed-phase column was a Luna C18 ODS2, 3 µm, (4.6 x 150mm) (Phenomenex® Torrance, CA, USA). The column was kept at room temperature. The HPLC was operated with mobile phase system consisting of methanolphosphate buffer solution pH 7.5 (0.03 M Na2HPO4, 0.007M NaH2PO4) 50/50 % v/v at flow rate of 1 ml/min and acetonitrile-water 23/77 % v/v at flow rate of 1 ml/min, for OTA and AFM1, respectively. Calibration curves were based on the analysis of triplicate standards solution at 5 concentration levels in matrix and resulted in good linear relationship between peak area and mycotoxins concentration (R 2 >0.999). The limits of detection (LOD) and quantitation (LOQ), calculated as threefold and tenfold the standard deviation of the intercepts of calibration curves are reported in table 1. The recovery (percentage of standard added to sample that is recovered after extraction and clean-up) of the extraction method was determined by sample fortification (Table 2) . Intra-day reproducibility was evaluated by analyzing three milk samples with mycotoxins to obtain three different concentrations (10, 50, and 100 ng/L). Day-to-day reproducibility was determined by analysis of three replicate samples of the three concentrations (10, 50, and 100 ng/L) on seven consecutive days. From the data obtained, intra-and interday coefficient of deviations (CV) were calculated. 
RESULTS AND DISCUSSION
A total of 185 infant cow's milk-based formula samples were analyzed. AFM1 was detected only in 2 samples (range 11.8-15.3 ng/L) from the same brand (n. = 10). The AFM1 contamination levels and incidence in infant formula marketed in Italy were lower than those observed in previous studies regarding milk analysis (Galvano et al., 1998; 2001) . These results are probably due to the increased attention paid in European countries to the presence of aflatoxins in feeds and milk products and suggest that regulatory limits appear to be helpful.
OTA was detected in 133 (72%) samples (range 35.1-689.5 ng/L). The most contaminated one was a pre-term ready-to-use preparation containing 689.5 ng/L of OTA. In contrast to AFM1, no regulation for OTA in milk exists, even though it has been suggested that the level of this toxin in cow's milk may exceed the TDI of 5 ng/kg b.w. per day for small children in some areas in Norway. The European legislation limit of 0.50 ppb (µg/L) for showed no significant (p>0.05) correlation between parameters.
It has been observed that OTA contamination was 80% in the ready-to-use preparations and 63% in the powdered samples. Pre-term and starter ready-to-use formula preparations showed the same incidence of positive samples (80%), while pre-term powdered formula showed 100% incidence and starter formula the 60%, although the numbers of pre-term powdered formula tested were insufficient to obtain an accurate picture of the incidence contamination (Table 4) .
Non-parametric statistical analyses (Mann Whitney test) were performed with OTA content for comparison of the different types of formulas, not establishing significant differences (p>0.05) between different groups. The OTA content in both powder and readyto-use formulas has been statistically evaluated to understand the influence of the aggregation The OTA concentrations determined in the different types of formulas were used to calculate mean daily and weekly dietary OTA intakes by infants on the basis of feeding tables provided by brands, under the assumption that they receive only formulas. The mean daily (JECFA) and a provisional tolerable weekly intake (PTWI) of 100 ng/kg b.w. was established.
In the present investigation, the average OTA levels in pre-term ready-to-use infant formula were sufficient to cause a higher intake of OTA than the suggested TDI and PTWI, while other formulations were below these limits.
Interestingly, OTA was also detected in milk from healthy mothers in Germany, Norway, Sweden, Hungary, Italy, Australia and Sierra Leone (Scott, 2005) . The present results are comparable with those obtained by Turconi et al. (2004) and Galvano et al. (2008) in two studies regarding human milk performed in Italy (198 of 231 samples contaminated with 1-57 ng/L and 74 of 82 samples contaminated with < 5 ng/L-405 ng/L, respectively), while are lower than those reported by Micco et al. (1991; 1995) (ranges 1700-6600 ng/L and 100-12000 ng/L, respectively).
Due to high toxicity and carcinogenic properties of OTA, its presence in milk is a concern. OTA is resistant to thermal inactivation and other varieties of food processing procedures, so to produce high quality milk, it is essential to keep feeds free from contamination by OTA. Mycotoxin concentrations in animal feed can be reduced by good manufacturing practice and good storage practices. On the other hand, infant formula In conclusion, the results of this study firstly indicate the OTA presence in infant cow's milk-based formulas and therefore, they point out the need to perform occurrence surveys in this area. The present study also suggests the usefulness of prevention programs especially when attempting to identify risk markers of the infant feed quality. Analysis of infant cow's milk-based formulas samples hence may serve as a marker of exposure to OTA. At the same time, OTA levels in milk indicate the exposure of new-born infants, which needs to be considered in the overall risk characterization . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 
